Earnings Feed
Start Free
Omada Health, Inc.·4

Jul 8, 8:14 PM ET

Cook Steven L. 4

4 · Omada Health, Inc. · Filed Jul 8, 2026

Research Summary

AI-generated summary of this filing

Updated

Omada Health (OMDA) CFO Steven L. Cook Exercises Options, Sells Shares

What Happened

  • Steven L. Cook, Chief Financial Officer of Omada Health (OMDA), exercised stock options to acquire a total of 35,600 shares (23,263 on 2026-07-01 and 12,337 on 2026-07-07 broken into 10,601, 1,042 and 694) by paying aggregate exercise prices of $294,070. He then sold the same total of 35,600 shares in open-market transactions, receiving aggregate proceeds of $814,341. The transactions resulted in net cash proceeds of approximately $520,271 (proceeds minus exercise cost).
  • These were option-exercise transactions (transaction code M) followed by sales (S), i.e., effectively a cashless exercise where newly acquired shares were sold.

Key Details

  • Dates and prices:
    • 2026-07-01: Exercised 23,263 shares at $8.28 (paid $192,618); sold 23,263 shares at a weighted avg $22.76 for $529,501 (trades ranged $22.11–$23.09). (F2)
    • 2026-07-07: Exercised 10,601 shares at $8.28 (paid $87,776); exercised 1,042 at $8.01 (paid $8,346); exercised 694 at $7.68 (paid $5,330). Sold 12,337 shares at a weighted avg $23.09 for $284,840 (trades ranged $23.00–$23.30). (F3)
  • Shares owned after transaction: Not disclosed in the provided filing details.
  • Footnotes of note:
    • F1: The sale(s) were made pursuant to a pre-established 10b5-1 trading plan adopted March 14, 2026.
    • F2/F3: Sales executed in multiple trades; reported prices are weighted averages and detailed per-trade info is available upon request.
    • F4–F6: Filing indicates different option grants have different vesting statuses—some options fully vested (F4), others vest monthly over four years from Feb 1, 2024 (F5) or Feb 1, 2025 (F6).
  • Filing timeliness: Filing date 2026-07-08 for transactions on 2026-07-01 and 2026-07-07; the filing does not indicate it was late.

Context

  • These transactions are routine for stock option exercises followed by sales (cashless exercise). Because the shares were exercised and immediately sold under a 10b5-1 plan, they do not necessarily signal a change in the insider’s view of the company; they primarily represent monetization of vested options.
  • Transaction codes: M = Option exercise/conversion; S = Open-market sale.

Insider Transaction Report

Form 4
Period: 2026-07-01
Omada Health, Inc.OMDA
Cook Steven L.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-07-01$8.28/sh+23,263$192,618→ 210,472 total
  • Sale

    Common Stock

    [F1][F2]
    2026-07-01$22.76/sh−23,263$529,501→ 187,209 total
  • Exercise/Conversion

    Common Stock

    2026-07-07$8.28/sh+10,601$87,776→ 197,810 total
  • Exercise/Conversion

    Common Stock

    2026-07-07$8.01/sh+1,042$8,346→ 198,852 total
  • Exercise/Conversion

    Common Stock

    2026-07-07$7.68/sh+694$5,330→ 199,546 total
  • Sale

    Common Stock

    [F1][F3]
    2026-07-07$23.09/sh−12,337$284,840→ 187,209 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-07-01−23,263→ 278,246 total
    Exercise: $8.28Exp: 2031-07-19→ Common Stock (23,263 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F4]
    2026-07-07−10,601→ 267,645 total
    Exercise: $8.28Exp: 2031-07-19→ Common Stock (10,601 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-07-07−1,042→ 19,792 total
    Exercise: $8.01Exp: 2034-02-08→ Common Stock (1,042 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F6]
    2026-07-07−694→ 21,528 total
    Exercise: $7.68Exp: 2035-01-27→ Common Stock (694 underlying)
Footnotes (6)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
  • [F2]This transaction was executed in multiple trades at prices ranging from $22.11 to $23.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $23.00 to $23.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]100% of the shares subject to the option are fully vested and exercisable.
  • [F5]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
  • [F6]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook|2026-07-08

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4